tirzepatide trial obesity without diabetes New drug delivers significant and long-lasting weight loss SURMOUNT-MMO: First trial on tirzepatide
Description
As patients lose weight, adjustments to blood pressure medications are often necessary to prevent hypotension
Both tirzepatide and semaglutide were associated with significant reductions in multiple disease categories, with 65 and 72 conditions reaching significance in high and moderate responders, respectively (Figure S3ab
Louisiana is the only exclusion
Instead of trying to eat three normal-sized meals that your suppressed appetite will not allow, switch to smaller, more frequent eating occasions
Both require the same precautions around a history of pancreatitis
